Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Pancreatic Ductal × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 5 Kidney Neoplasms 3 Ovarian Neoplasms 1 Neoplasms 1 Kidney Diseases 1 Carcinoma, Pancreatic Ductal 1

Interventions

Gemcitabine 3 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 napabucasin 1 PEGPH20 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00471146 2012-07-16

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Pfizer

Phase 3 Completed

630 enrolled 13 charts

Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡